AMENDMENT NO. 1 TO SHAREHOLDER RIGHTS AGREEMENT
AMENDMENT
NO. 1 TO
Amendment No.
1, dated as of January 24, 2007 (the “Amendment”), to the Shareholder Rights
Agreement, dated as of October 8, 2002 (the “Rights Agreement”), by and
between DOV Pharmaceutical, Inc., a Delaware corporation (the “Company”), and
Continental Stock Transfer & Trust Co., a federally chartered trust
company (the “Rights Agent”).
WITNESSETH
WHEREAS,
pursuant to Section 27 of the Rights Agreement, the Company may prior to a
Section 11(a)(ii) Event (as defined in the Rights Agreement) supplement or
amend
the Rights Agreement without the approval of any holders of certificates
representing shares of common stock of the Company or any other securities
of
the Company; and
WHEREAS,
the Company now desires to amend the Rights Agreement as set forth in this
Amendment, and pursuant to Section 27 of the Rights Agreement, the Board of
Directors of the Company hereby directs that the Rights Agreement should be
amended as set forth in this Amendment.
NOW,
THEREFORE, in consideration of the premises and the mutual agreements herein
set
forth, the parties hereby agree as follows:
1. Amendments
to Section 1.
(a) Section
1
of the Rights Agreement is hereby amended by adding the following
definitions:
(ll)
“Debentures”
shall
mean the Company’s 2.50% Convertible Subordinated Debentures due 2025, issued
under that certain Indenture, dated as of December 22, 2004, by and between
the Company and Xxxxx Fargo Bank, National Association, as Trustee.
(mm) “Exchange
Offer”
shall
have the meaning set forth in the Restructuring Support Agreement.
(nn) “Noteholders”
shall
mean the holders of the Debentures.
(oo) “Restructuring
Support Agreement”
shall
mean the Restructuring Support Agreement, dated as of January 24, 2007, by
and among the Company and certain Noteholders named therein, as amended from
time to time.
(b) The
definition of “Acquiring
Person”
in
Section 1(a) of the Rights Agreement is hereby amended by inserting the
following sentence at the end thereof:
“Notwithstanding
the foregoing or any other provision of this Agreement to the contrary,
none of (i) the negotiation, execution and delivery of the Restructuring
Support Agreement or any other documents referred to therein, (ii)
the
exercise by the parties thereto of their respective rights under
the
Restructuring Support Agreement or any other documents referred to
therein, and (iii) the consummation of the Exchange Offer or any
of the
other transactions contemplated by the Restructuring Support Agreement,
shall be deemed to result in any Noteholder or any other Person becoming
an Acquiring Person.”
|
2. Amendment
to Section 3(a).
Section
3(a) of the Rights Agreement is hereby amended to add the following sentence
at
the end thereof:
“Notwithstanding
anything in this Agreement to the contrary, a Distribution Date shall
not
be deemed to have occurred as a result of any of (i) the negotiation,
execution and delivery of the Restructuring Support Agreement or
any other
documents referred to therein, (ii) the exercise by the parties thereto
of
their respective rights under the Restructuring Support Agreement
or any
other documents referred to therein, and (iii) the consummation of
the
Exchange Offer or any of the other transactions contemplated by the
Restructuring Support Agreement.”
|
3. Effectiveness.
This
Amendment shall be deemed effective as of the date first above written, as
if
executed on such date. Except as expressly set forth herein, this Amendment
shall not by implication or otherwise alter, modify, amend or in any way affect
any of the terms, conditions, obligations, covenants or agreements contained
in
the Rights Agreement, all of which are ratified and affirmed in all respects
and
shall continue in full force and effect and shall be otherwise
unaffected.
4. Governing
Law.
This
Amendment shall be deemed to be a contract made under the laws of the State
of
Delaware and for all purposes shall be governed by and construed in accordance
with the laws of such state applicable to contracts to be made and performed
entirely within such state.
5. Counterparts.
This
Amendment may be executed in any number of counterparts, each of which shall
for
all purposes be deemed an original, and all of which together shall constitute
but one and the same instrument.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
2
IN
WITNESS WHEREOF, the parties hereto have caused this Amendment No. 1 to
Shareholder Rights Agreement to be duly executed as of the day and year first
above written.
DOV
PHARMACEUTICAL, INC.
|
||
|
|
|
By: | /s/ Xxxxxxx Xxxxxx | |
Xxxxxxx
Xxxxxx
|
||
President and Chief Financial Officer |
CONTINENTAL
STOCK TRANSFER & TRUST CO.,
|
||
as
Rights Agent
|
||
|
|
|
By: | /s/ Xxxxx Xxxxxxxx | |
Name:
Xxxxx Xxxxxxxx
|
||
Title:
Vice President
|
3